The Explorer Live cloud-based digital platform communicates critical information through an interactive digital playbook, enabling surgical teams to access customized information for specific team roles. The platform facilitates UroLift System trainer collaboration with Urology surgical teams during live procedures from anywhere in the country through remote video connectivity.
“Our clinical teams are able to reinforce the best practices and techniques for the UroLift System, and ultimately help clinicians become more proficient with the device so they can achieve better patient outcomes,” said
“We have seen a tremendous response to Explorer Live from both our teams out in the field and the medical community they serve. And we are excited to offer physicians high quality remote learning opportunities that can increase BPH patient access to effective treatment with the UroLift System,” said
“We are pleased to support
With Explorer Live, all the processes and workflows of the UroLift System procedure are accessible before a surgical team performs any procedure. Through the platform, surgeons can:
- Access images, PDFs, and videos about the UroLift System, surgical techniques, and a step-by-step workflow for each team member. The digital playbook is customized to the clinical team's role, procedure type, and surgeon preferences.
- Broadcast in real-time to provide clinical education, remote collaboration, or demonstrations.
- Capture robust video and procedural data to be used by the surgeon or in partnership with a medical device company for performance tracking, identifying opportunities to reduce variability, post-market feedback and analysis, and future product development.
The UroLift System is a minimally invasive treatment for lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). It can result in rapid relief and recovery for men living with symptoms of an enlarged prostate,1 and provides an alternative therapy with a risk profile better than reported for surgical procedures such as TURP.2 The UroLift permanent implants are delivered during an outpatient procedure and relieve prostate obstruction without cutting, heating, or removing prostate tissue.
For more information on UroLift, visit urolift.com. To learn more about Explorer Live, visit explorersurgical.com.
About
About Teleflex Interventional Urology
The Teleflex Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive, and clinically effective devices that address unmet needs in the field of urology. Our focus is on improving the standard of care for patients with BPH using the UroLift® System, a minimally invasive, permanent implant system that treats symptoms while preserving sexual function. *1,3,4 Learn more at urolift.com.
About Explorer Surgical
Explorer Surgical is dedicated to relentlessly innovating and developing scalable digital technologies to put best practices in the hands of all procedural teams. As a leader in creating state-of-the-art solutions, our cutting-edge, cloud-based, digital platform empowers medical device companies to disseminate procedural best practices and remotely connect with providers in real-time. Our goal is to demystify the black box of the operating room with an on-demand procedure playbook, real-time video collaboration and performance tracking tools to support medical device companies, accelerate product adoption, reinforce techniques, and support successful outcomes.
Founded in 2015, Explorer Surgical started as a research project at the
For more information or to schedule a demo of Explorer Live's platform, visit explorersurgical.com or follow us on LinkedIn.
Contacts:
Lawrence Keusch
Vice President, Investor Relations and Strategy Development
Vice President, Investor Relations
investors.teleflex.com
610.948.2836
Media:
nicole@healthandcommerce.com
References
* No instances of new, sustained erectile or ejaculatory dysfunction in the L.I.F.T. pivotal study.
- Roehrborn, J Urol 2013
- Sonksen, Eur Urol 2015
- AUA BPH Guidelines 2003, 2020
- McVary, J Sex Med 2016
MAC002247-01 Rev A
Source:
2021 GlobeNewswire, Inc., source